Dr. Eherts joined Allergan (then Actavis) Pharmaceuticals in March of 2014 as Vice President of Global EHS. Allergan is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.
Prior to Allergan, David has worked over 30 years in the fields of Safety and EHS starting as a toxicologist in Pre-Clinical Drug Safety Assessment at Merck. He moved to EHS and has held positions of increasing responsibility at Merck, Sanofi-Aventis, Purdue Pharmaceuticals and just prior to Allergan, he led Aviation and Product Safety at Sikorsky Aircraft as their Vice President and Chief Safety Officer. His experience and expertise span aviation, human and organizational performance (HOP), environmental toxicology, occupational health, potent compound control and management systems in the aerospace, healthcare and pharmaceutical industries. Dave holds Bachelor’s degrees in Chemistry and Biology and a Masters and PhD in Environmental Toxicology from Drexel University.
In addition to his day job, David was recently appointed by the US Secretary of Labor to the Federal Whistleblower Protection Advisory Committee. Less controversially, he’s served on advisory boards for ORCHSE's Executive Business Issues Forum, CAE Flight Training and the board of directors for Occupational Knowledge International (an NGO dedicated to preventing overexposures to toxic chemicals in developing countries) and SoundWaters (protecting the environment of Long Island Sound). In his spare time, he's an adjunct professor at New York Medical College and at Tulane University where he teaches courses in EHS Management, Finance, Environmental Toxicology, Industrial Hygiene and Occupational Health.